Patents Assigned to Viron Therapeutics
  • Myxoma chemokine binding protein
    Patent number: 6589933
    Abstract: The present invention provides a method of use for a novel chemokine binding protein 5(type-2 CBP) encoded by poxviruses and having amino acid sequence homology with the Shope fibroma virus T1 family of proteins against disease syndromes associated with acute or chronic dysregulated inflammatory responses.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: July 8, 2003
    Assignee: Viron Therapeutics, Inc.
    Inventors: Grant McFadden, Alexandra Lucas
  • Chemokine binding protein and methods of use therefor
    Patent number: 6495515
    Abstract: The present invention provides a method of use for a novel type I chemokine binding protein encoded by poxviruses and having amino acid sequence homology with the myxoma virus T7 interferon-&ggr; receptor homolog against disease syndromes associated with acute or chronic dysregulated inflammatory responses.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: December 17, 2002
    Assignee: Viron Therapeutics, Inc.
    Inventors: Grant McFadden, Alexandra Lucas
  • Methods of treating inflammation and compositions therefor
    Patent number: 5939525
    Abstract: Compositions and methods for treating inflammatory cell infiltration in a tissue of a mammalian subject are provided. The method involves administering a therapeutically effective amount of SERP-1, SERP-1 analog or biologically active fragment thereof admixed with a pharmaceutically acceptable carrier to a subject in need of such treatment. Biologically active SERP-1 analogs are also provided. The compositions and methods of the present invention are useful for treating numerous inflammatory based diseases and injuries.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: August 17, 1999
    Assignee: Viron Therapeutics, Inc.
    Inventors: D. Grant McFadden, Alexandra Lucas
  • Methods of treating inflammation and compositions therefor
    Patent number: 5917014
    Abstract: Compositions and methods for treating inflammatory cell infiltration in a tissue of a mammalian subject are provided. The method involves administering a therapeutically effective amount of SERP-1, SERP-1 analog or biologically active fragment thereof admixed with a pharmaceutically acceptable carrier to a subject in need of such treatment. Biologically active SERP-1 analogs are also provided. The compositions and methods of the present invention are useful for treating numerous inflammatory based diseases and injuries.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 29, 1999
    Assignee: Viron Therapeutics, Inc.
    Inventors: D. Grant McFadden, Alexandra Lucas